Hangzhou Huajin Pharmaceutical Co., Ltd is a modern high-tech pharmaceutical manufacturing enterprise, specializing in bio-tech and the manufacture of biological agent, raw materials as well as intermediates, integrating domestic&international sales with scientific research, industry and trade. The headquarter is located in Hangzhou High-tech Development Zone, and the plant with 10,000 square meters area was set up in 2004, located in Lingang Industry Zone, Xiaoshan District, Hangzhou. It has the self-managing rights of inport and export , with the approval of the ministry of foreign economic relations and trade department from octerber,2003.

Huajin Pharma has a registered capital of RMB 6 millions, total assets of RMB 21 millions and more than 100 employees. 60% of the employees are professional staffs in pharmacy, medical, and chemical engineering etc. Up to now, Huajin Pharma has gained 5 patents, such as the Preparation Method of Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules and the Preparation Method of Human Placenta RNA for Injection etc.

Our main products are Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules, Transfer Factors Capsules, Pearl Powder Capsules and many biological raw materials, like Cerebroprotein hydrolysate(Cerebrolysin concentrate), Hepatocyte Growth-Promoting Factors, Transfer Factors, Thymomodulin, Thymopentin, Vidarabine etc. In particular, Cerebroprotein Hydrolysate and HGF Capsules were assessed as “High-tech products” by Science and Technology Department of Zhejiang Province, “Brand name and Quality products ” by Science and Technology Association of Zhejiang Province. Huajin Pharma owns four trade marks, “HJBC” ”Jingdao” ”Fulekang” and ” Fujin”, and “Fujin” was evaluated as “Well-known Brand” by Government of Hangzhou. Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules have been registered and imported into Korea South, and our raw materials are exported to several countries and regions.

All the staffs in Huajin try to take an initiative in the fast-changing pharmaceutical industry and to contribute to the improvement of the relevant market, by introducing new technologies/new trends and successful experiences through symposia co-organized together with foreign partners. And needless to say, we will do our best to contribute to the improvement of human health for our better quality of life in the future.


Registration date: Nov 11, 2008